243 related articles for article (PubMed ID: 17290303)
1. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.
Meyer-Lindenberg A; Straub RE; Lipska BK; Verchinski BA; Goldberg T; Callicott JH; Egan MF; Huffaker SS; Mattay VS; Kolachana B; Kleinman JE; Weinberger DR
J Clin Invest; 2007 Mar; 117(3):672-82. PubMed ID: 17290303
[TBL] [Abstract][Full Text] [Related]
2. An association study between PPP1R1B gene and schizophrenia in the Chinese population.
Hu JX; Yu L; Shi YY; Zhao XZ; Meng JW; He G; Xu YF; Feng GY; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1303-6. PubMed ID: 17618027
[TBL] [Abstract][Full Text] [Related]
3. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
Kunii Y; Hyde TM; Ye T; Li C; Kolachana B; Dickinson D; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2014 Feb; 19(2):192-9. PubMed ID: 23295814
[TBL] [Abstract][Full Text] [Related]
4. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia.
Feldcamp LA; Souza RP; Romano-Silva M; Kennedy JL; Wong AH
Schizophr Res; 2008 Aug; 103(1-3):192-200. PubMed ID: 18573638
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder.
Yoshimi A; Takahashi N; Saito S; Ito Y; Aleksic B; Usui H; Kawamura Y; Waki Y; Yoshikawa T; Kato T; Iwata N; Inada T; Noda Y; Ozaki N
Schizophr Res; 2008 Mar; 100(1-3):334-41. PubMed ID: 18055181
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of DARPP-32 as a candidate gene for schizophrenia.
Li CH; Liao HM; Hung TW; Chen CH
Schizophr Res; 2006 Oct; 87(1-3):1-5. PubMed ID: 16750903
[TBL] [Abstract][Full Text] [Related]
7. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.
Kunii Y; Hino M; Matsumoto J; Nagaoka A; Nawa H; Kakita A; Akatsu H; Hashizume Y; Yabe H
Sci Rep; 2019 Oct; 9(1):14877. PubMed ID: 31619735
[TBL] [Abstract][Full Text] [Related]
8. Dopamine modulates attentional control of auditory perception: DARPP-32 (PPP1R1B) genotype effects on behavior and cortical evoked potentials.
Li SC; Passow S; Nietfeld W; Schröder J; Bertram L; Heekeren HR; Lindenberger U
Neuropsychologia; 2013 Jul; 51(8):1649-61. PubMed ID: 23639477
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
10. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
Kunii Y; Miura I; Matsumoto J; Hino M; Wada A; Niwa S; Nawa H; Sakai M; Someya T; Takahashi H; Kakita A; Yabe H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():123-8. PubMed ID: 24704945
[TBL] [Abstract][Full Text] [Related]
11. [DARPP-32 in the patients with endogenous psychosis].
Ishikawa M; Mizukami K
Brain Nerve; 2007 Nov; 59(11):1257-63. PubMed ID: 18044203
[TBL] [Abstract][Full Text] [Related]
12. DARPP-32: from neurotransmission to cancer.
Belkhiri A; Zhu S; El-Rifai W
Oncotarget; 2016 Apr; 7(14):17631-40. PubMed ID: 26872373
[TBL] [Abstract][Full Text] [Related]
13. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
Egan MF; Straub RE; Goldberg TE; Yakub I; Callicott JH; Hariri AR; Mattay VS; Bertolino A; Hyde TM; Shannon-Weickert C; Akil M; Crook J; Vakkalanka RK; Balkissoon R; Gibbs RA; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12604-9. PubMed ID: 15310849
[TBL] [Abstract][Full Text] [Related]
14. Variation of the gene coding for DARPP-32 (PPP1R1B) and brain connectivity during associative emotional learning.
Curčić-Blake B; Swart M; Ter Horst GJ; Langers DR; Kema IP; Aleman A
Neuroimage; 2012 Jan; 59(2):1540-50. PubMed ID: 21878394
[TBL] [Abstract][Full Text] [Related]
15. The involvement of DARPP-32 in the pathophysiology of schizophrenia.
Wang H; Farhan M; Xu J; Lazarovici P; Zheng W
Oncotarget; 2017 Aug; 8(32):53791-53803. PubMed ID: 28881851
[TBL] [Abstract][Full Text] [Related]
16. Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.
Uematsu K; Futter M; Hsieh-Wilson LC; Higashi H; Maeda H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2005 Dec; 95(6):1642-52. PubMed ID: 16300646
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function.
Kempf L; Nicodemus KK; Kolachana B; Vakkalanka R; Verchinski BA; Egan MF; Straub RE; Mattay VA; Callicott JH; Weinberger DR; Meyer-Lindenberg A
PLoS Genet; 2008 Nov; 4(11):e1000252. PubMed ID: 18989458
[TBL] [Abstract][Full Text] [Related]
18. Influence of DARPP-32 genetic variation on BOLD activation to happy faces.
Persson N; Lavebratt C; Ebner NC; Fischer H
Soc Cogn Affect Neurosci; 2017 Oct; 12(10):1658-1667. PubMed ID: 29048604
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.
Kotecha S; Lebot MN; Sukkarn B; Ball G; Moseley PM; Chan SY; Green AR; Rakha E; Ellis IO; Martin SG; Storr SJ
Sci Rep; 2019 Nov; 9(1):16987. PubMed ID: 31740718
[TBL] [Abstract][Full Text] [Related]
20. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.
Kunii Y; Ikemoto K; Wada A; Yang Q; Kusakabe T; Suzuki T; Niwa S
Med Mol Morphol; 2011 Dec; 44(4):190-9. PubMed ID: 22179181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
